[When in pregnancy should screening for Chlamydia be carried out?].
One goal of every prenatal care should be the diagnosis of a cervical infection with Chlamydia trachomatis and the prevention of its transmission to the neonate. Therefore, we studied the questions (1) at which gestational age a screening would be most meaningful and (2) whether the woman's medical history, a vaginal smear or cervical cerclage suggests any risk of infection. 11 of 121 pregnant women (9.1%) had a positive test for cervical infection with Chlamydia trachomatis at their booking visit. More than half of them had a spontaneous remission at the follow-up visit. Practically, all newborns to infected mothers (at follow-up visits) had a positive test as well. We did not find any relationship between the medical history, vaginal smear or cervical cerclage and the incidence of Chlamydia trachomatis infection. In conclusion, we propose a screening for Chlamydia trachomatis infection of all pregnant women between the 34th and 38th week of gestation and treatment of infected individuals with erythromycin (4 x 500 mg t.i.d.).
Schlögl
H
H
II. Universitäts-Frauenklinik Wien.
Rudelstorfer
R
R
Kosian
K
K
D001431:Bacteriological Techniques; D002584:Cervix Uteri / Q000382:microbiology; D002690:Chlamydia Infections / Q000517:prevention & control*; D002692:Chlamydia trachomatis / Q000302:isolation & purification; D003228:Conjunctiva / Q000382:microbiology; D003235:Conjunctivitis, Inclusion / Q000517:prevention & control; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008403:Mass Screening; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000517:prevention & control*; D012307:Risk Factors; D002575:Uterine Cervicitis / Q000517:prevention & control*
Wann sollte in der Schwangerschaft ein Chlamydiennachweis erbracht werden?